Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
J Clin Pathol ; 62(12): 1127-35, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19946100

ABSTRACT

BACKGROUND: Well differentiated liposarcomas (WDLPS) and dedifferentiated liposarcomas (DDLPS) have been shown to have supernumerary chromosomes with amplified sequences of the MDM2 and CDK4 genes. MDM2 and CDK4 protein overexpression have also been identified in these tumours. AIM: To investigate whether immunohistochemistry (IHC) for MDM2 and CDK4 can be used to diagnose WDLPS and DDLPS. METHODS: IHC for MDM2/CDK4 was carried out on a series of 129 paraffin-embedded lipomatous and non-lipomatous soft tissue tumours. The cases were divided into four groups: WDLPS (n = 19), DDLPS (n = 10), benign adipocytic tumours (BAT) (n = 17), and other mesenquimal tumours (OMT) (n = 83). IHC results were compared in each group and the diagnostic efficacy of the test in identifying WDLPS and DDLPS among the other soft tissue tumours was determined. A percentage of tumour cell positivity was evaluated to better characterise the pattern of tumour immunostaining. RESULTS: Sensitivity and specificity of positive MDM2 and CDK4 immunostainings to identify WDLPS among BAT was 100% and 58.8%, and 68.4% and 88.2%, respectively. When distinguishing DDLPS from OMT, sensitivity and specificity of MDM2 and CDK4 were 90% and 65%, and 70% and 96.3%, respectively. The highest specificity was achieved when a case was considered positive with strong and diffuse immunoreactivity in more than 30% of the neoplastic cells (94.1% and 100%, and 77.1% and 98.8%, respectively). CONCLUSION: Detection of MDM2/CDK4 protein overexpression by IHC can be used by pathologists to diagnose WDLPS and DDLPS. Considering a strong and diffuse immunostaining pattern in most of the neoplastic cells achieves the best results in identifying these tumours.


Subject(s)
Biomarkers, Tumor/metabolism , Cyclin-Dependent Kinase 4/metabolism , Liposarcoma/diagnosis , Proto-Oncogene Proteins c-mdm2/metabolism , Soft Tissue Neoplasms/diagnosis , Adult , Aged , Aged, 80 and over , Cell Differentiation , Female , Humans , Immunoenzyme Techniques , Liposarcoma/pathology , Male , Middle Aged , Neoplasm Proteins/metabolism , Sensitivity and Specificity , Soft Tissue Neoplasms/pathology
2.
Bioorg Med Chem Lett ; 10(17): 1975-8, 2000 Sep 04.
Article in English | MEDLINE | ID: mdl-10987430

ABSTRACT

A series of substituted 2-aminopyridines was prepared and evaluated as inhibitors of human nitric oxide synthases (NOS). 4,6-Disubstitution enhanced both potency and specificity for the inducible NOS with the most potent compound having an IC50 of 28 nM.


Subject(s)
Aminopyridines/chemical synthesis , Enzyme Inhibitors/chemical synthesis , Nitric Oxide Synthase/antagonists & inhibitors , Aminopyridines/pharmacology , Enzyme Inhibitors/pharmacology , Humans , Structure-Activity Relationship
3.
Inflammation ; 23(1): 51-62, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10065761

ABSTRACT

A model of acute lung injury induced by intravenous phorbol myristate acetate (PMA) is described. The model is characterized by the accumulation of polymorphonuclear leukocytes (PMNs) and a hemorrhagic edema in bronchoalveolar lavage (BAL) fluid when measured 6 h following the administration of PMA (60 microg/kg, i.v.). It was also determined that PMA induces acute leukopenia and neutropenia which were maximal at 5 min following the injection of PMA and were sustained for at least 6 h, with circulating leukocyte numbers returning to control values by 24 h. The extents to which the inflammatory and systemic changes induced by PMA were dependent on the surface expression on leukocytes of the beta2-integrins was assessed by comparing responses to PMA in control animals and animals pretreated with the anti-CD18 monoclonal antibody IB4. The administration of IB4 (1 mg/kg, i.v.) 15 min before PMA did not alter the time course or extent of PMA-induced leukopenia and neutropenia. In contrast IB4 administration (0.1 to 1 mg/kg) produced a dose dependent inhibition of PMN accumulation and plasma extravasation measured in BAL fluid. IB4 (1 mg/kg) completely inhibited PMA evoked increases in plasma extravasation (94.5 +/- 1.7%, N = 4) and hemorrhage (95.2 +/- 2.1%, N = 4) whereas PMN accumulation in BAL fluid was inhibited by 77.8 +/- 3.8% (mean +/- SEM, N = 4). Thus, a small, but reproducible, component of the PMA-induced PMN accumulation was not inhibited using this regimen of IB4 administration. If IB4 administration was delayed for 3 h post injection of PMA and bronchoalveolar lavage performed 3 h later, the extents of PMN accumulation and edema formation were similar to those observed 3 h following PMA challenge in control animals not dosed with IB4. This suggests that administration of IB4 during an ongoing inflammatory response is capable of preventing the further development of inflammatory changes and further supports the therapeutic potential of CD18 blockade in conditions such as adult respiratory distress syndrome.


Subject(s)
Antibodies, Monoclonal/pharmacology , CD18 Antigens/immunology , Endothelium, Vascular/pathology , Neutrophils/physiology , Tetradecanoylphorbol Acetate/pharmacology , Animals , Cell Movement/drug effects , Endothelium, Vascular/drug effects , Female , Leukocyte Count/drug effects , Neutropenia/chemically induced , Neutropenia/pathology , Neutrophils/drug effects , Rabbits
4.
Endocrinology ; 139(12): 4920-7, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9832429

ABSTRACT

A role for peroxisome proliferator-activated receptors, PPAR gamma and PPAR alpha, as regulators of energy homeostasis and lipid metabolism, has been suggested. Recently, three distinct uncoupling protein isoforms, UCP-1, UCP-2, and UCP-3, have also been identified and implicated as mediators of thermogenesis. Here, we examined whether in vivo PPAR gamma or PPAR alpha activation regulates the expression of all three UCP isoforms. Rats or lean and db/db mice were treated with PPAR gamma [thiazolidinedione (TZD)] or PPAR alpha (WY-14643) agonists, followed by measurement of messenger RNAs (mRNAs) for UCP-1, UCP-2, and UCP-3 in selected tissues where they are expressed. TZD treatment (AD 5075 at 5 mg/kg x day) of rats (14 days) increased brown adipose tissue (BAT) depot size and induced the expression of each UCP mRNA (3x control levels for UCP-1 and UCP-2, 2.5x control for UCP-3). In contrast, UCP-2 and UCP-3 mRNA levels were not affected in white adipose tissue or skeletal muscle. Chronic (30 days) low-dose (0.3 mg/kg x day) TZD treatment induced UCP-1 mRNA and protein in BAT (2.5x control). In contrast, chronic TZD treatment (30 mg/kg x day) suppressed UCP-1 mRNA (>80%) and protein (50%) expression in BAT. This was associated with further induction of UCP-2 expression (>10-fold) and an increase in the size of lipid vacuoles, a decrease in the number of lipid vacuoles in each adipocyte, and an increase in the size of the adipocytes. TZD treatment of db/db mice (BRL 49653 at 10 mg/kg x day for 10 days) also induced UCP-1 and UCP-3 (but not UCP-2) expression in BAT. PPAR alpha is present in BAT, as well as liver. Treatment of rats or db/db mice with WY-14643 did not affect expression of UCP-1, -2, or -3 in BAT. Hepatic UCP-2 mRNA was increased (4x control level) in db/db and lean mice, although this effect was not observed in rats. Thus, in vivo PPAR gamma activation can induce expression of UCP-1, -2, and -3 in BAT; whereas chronic-intense PPAR gamma activation may cause BAT to assume white adipose tissue-like phenotype with increased UCP-2 levels. PPAR alpha activation in mice is sufficient to induce liver UCP-2 expression.


Subject(s)
Carrier Proteins/genetics , Gene Expression Regulation/physiology , Membrane Proteins/genetics , Receptors, Cytoplasmic and Nuclear/physiology , Thiazolidinediones , Transcription Factors/physiology , Adipose Tissue, Brown/cytology , Adipose Tissue, Brown/drug effects , Adipose Tissue, Brown/metabolism , Animals , Carrier Proteins/metabolism , Dose-Response Relationship, Drug , Ion Channels , Male , Membrane Proteins/metabolism , Mice , Mice, Inbred C57BL , Mitochondrial Proteins , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Thiazoles/pharmacology , Time Factors , Uncoupling Protein 1
5.
J Exp Med ; 178(6): 1913-21, 1993 Dec 01.
Article in English | MEDLINE | ID: mdl-7504053

ABSTRACT

Equilibrium binding studies on canine mononuclear and granulocytic cells allow the identification of a single high affinity receptor for the human C-C chemokine RANTES (dissociation constant, 14 +/- 8 pM), that, in contrast to the human RANTES receptor, has no affinity for human macrophage inflammatory protein 1 alpha (hMIP-1 alpha). A single intradermal injection of hRANTES in dog resulted in eosinophil- and macrophage-rich inflammatory sites within 4 h. Cell infiltration peaked at 16-24 h after hRANTES injection. There was histological evidence of intravascular activation of eosinophils at 4 h, although eosinophils in the vasculature and interstitium contained apparently intact granules. Monocytes were the predominant cells adherent to venular endothelium at 16-24 h. Human MIP-1 alpha elicited no response in canine dermis, whereas monocyte chemoattractant protein 1 caused mild perivascular cuffing with monocytes. In contrast, human interleukin 8 induced a neutrophilic dermal infiltrate that was maximal by 4 h after challenge. This provides the first direct evidence in vivo that RANTES has significant proinflammatory activity and, in addition, could be a mediator in atopic pathologies characterized by eosinophilic and monocytic inflammatory responses.


Subject(s)
Cytokines/pharmacology , Eosinophils/immunology , Inflammation/chemically induced , Interleukin-8/pharmacology , Lymphokines/pharmacology , Monocytes/immunology , Monokines/pharmacology , Proteins/pharmacology , Receptors, Chemokine , Animals , Antimicrobial Cationic Peptides , Chemokine CCL3 , Chemokine CCL4 , Chemokine CCL5 , Chemotaxis, Leukocyte , Dogs , Dose-Response Relationship, Drug , Macrophage Inflammatory Proteins , Receptors, CCR5 , Receptors, Immunologic/metabolism , Skin/cytology , Skin/immunology , Species Specificity
6.
J Exp Med ; 177(3): 851-6, 1993 Mar 01.
Article in English | MEDLINE | ID: mdl-7679712

ABSTRACT

Equilibrium binding studies with recombinant human chemoattractant cytokines Rantes and monocyte chemoattractant protein 1 (MCP-1) on monocytic THP-1 cells have allowed the functional identification of two distinct receptors for C-C chemokines. One is a novel oligospecific receptor with high affinity for Rantes (50% maximal inhibitory concentration [IC50], 0.68 nM) and low affinity (IC50, 35 nM) for MCP-1, while the other is the previously described specific receptor for MCP-1 (IC50, 0.5 nM). Receptor affinity for Rantes is enhanced on preparation of isolated membranes with a 12-fold decrease in receptor Kd. The basis of this enhancement is not understood. The Rantes receptor appears to be G protein linked, as binding activity is abolished by guanosine 5'-O-(3-thiotriphosphate) (IC50, 7.3 nM). In contrast to the consequences of MCP-1 binding, we were unable to demonstrate ligand-dependent calcium fluxes on binding of Rantes to human monocytes or THP-1 cells. The binding of Rantes and MCP-1 to mononuclear cells from dog, rabbit, and rat were tested. While high affinity binding could be demonstrated in dog and rabbit, differences in ligand-induced Ca2+ fluxes could be shown between species. This suggests that receptor-ligand interactions and receptor coupling is best examined with autologous receptors and cytokine.


Subject(s)
Chemotactic Factors/metabolism , Guanosine Triphosphate/metabolism , Lymphokines/metabolism , Monocytes/chemistry , Receptors, Cell Surface/analysis , Animals , Calcium/metabolism , Cells, Cultured , Chemokine CCL2 , Chemokine CCL5 , Dogs , Humans , Monocytes/metabolism , Monocytes/ultrastructure , Protein Binding , Rabbits , Rats , Receptors, Cell Surface/metabolism , Species Specificity
7.
Br J Pharmacol ; 106(2): 287-94, 1992 Jun.
Article in English | MEDLINE | ID: mdl-1356557

ABSTRACT

1. The intradermal administration of endothelial IL-8 (IL-8(1-77) or monocyte derived IL-8 (IL-8(1-72) to rabbits produced a concentration-dependent increase in plasma extravasation and an accumulation of polymorphonuclear leukocytes (PMNs) when measured over a 3 h time period. When plasma extravasation and PMN accumulation were measured over a 30 min time period no significant increases in PMN accumulation or plasma extravasation were observed in response to IL-8 alone. However, under these conditions, the addition of prostaglandin E2 (100 pmol) produced a significant potentiation of IL-8-induced plasma extravasation. There was no significant difference between the biological activities of IL-8(1-77) and IL-8(1-72). 2. Plasma extravasation and PMN accumulation induced by IL-8 were inhibited in rabbits pretreated with the monoclonal antibody designated IB4 (1 mg kg-1, i.v.) directed against the common beta chain (CD18) of the leukocyte integrins. 3. The intra-articular administration to rabbits of IL-8(1-77) (1 nmol) resulted 24 h later in the appearance of a mixed population of leukocytes (PMNs and mononuclear cells) in synovial lavage fluid. Biochemical analyses revealed the presence of an increased level of sulphated proteoglycans (sPG) and of the metalloproteinase stromelysin. Pretreatment of rabbits with IB4 (3 mg kg-1, i.v.) inhibited the accumulation of PMNs but had no effect on the mononuclear infiltrate nor on the levels of sPG or stromelysin. 4. The intradermal or intra-articular injection of E. coli-derived endotoxin induced similar inflammatory changes to those observed with IL-8.The possibility that the biological activities of IL-8 were attributable to minor contamination with endotoxin is unlikely for two reasons. Firstly, biological effects of endotoxin were observed at levels greater than that contained in the IL-8 preparation. Secondly,reduction of the endotoxin content of the IL-8 preparation by a factor of 10 did not produce a concomitant reduction in the observed biological activity of the IL-8.


Subject(s)
Antigens, CD/physiology , Dermatitis/physiopathology , Interleukin-8/physiology , Synovitis/physiopathology , Animals , Antibodies, Monoclonal/immunology , CD18 Antigens , Endotoxins/analysis , Escherichia coli/metabolism , Female , Interleukin-8/analysis , Matrix Metalloproteinase 3 , Metalloendopeptidases/metabolism , Neutrophils/immunology , Proteoglycans/metabolism , Rabbits , Synovial Fluid/cytology , Synovial Fluid/metabolism , Therapeutic Irrigation
8.
Biochem Biophys Res Commun ; 159(2): 763-9, 1989 Mar 15.
Article in English | MEDLINE | ID: mdl-2930541

ABSTRACT

When human PMN were plated on fetal calf serum-coated polystyrene surfaces, addition of TNF-alpha, FMLP or PMA elicited adhesion and H2O2 formation. These effects of TNF-alpha and FMLP, but not of PMA, were impaired by removal of extracellular Ca2+. In addition, H2O2 formation induced by FMLP but not by TNF-alpha or PMA was inhibited by prior treatment with pertussis toxin (250-500 ng/ml). Thus, although the sequelae of TNF-alpha-receptor interaction on human PMN remain to be characterized in detail, they do not involve a pertussis toxin-sensitive GTP-binding protein.


Subject(s)
Neutrophils/metabolism , Oxygen Consumption , Pertussis Toxin , Tumor Necrosis Factor-alpha , Virulence Factors, Bordetella/pharmacology , Calcium/metabolism , Cell Adhesion/drug effects , Fetal Blood , Free Radicals , Humans , Hydrogen Peroxide/biosynthesis , Kinetics , N-Formylmethionine Leucyl-Phenylalanine , Neutrophils/drug effects , Neutrophils/physiology , Oxygen Consumption/drug effects , Tetradecanoylphorbol Acetate
9.
Biochem Pharmacol ; 37(18): 3511-4, 1988 Sep 15.
Article in English | MEDLINE | ID: mdl-2844191

ABSTRACT

Oxazolone-induced delayed hypersensitivity in mice produced swelling with concomitant increased tissue levels of leukotrienes and prostaglandins. Pharmacological agents were coapplied topically with oxazolone at the time of challenge in an attempt to modulate the immune-based inflammation. Dexamethasone inhibited both swelling and increases in eicosanoid levels. Indomethacin reduced prostaglandin levels but failed to inhibit swelling or reduce leukotriene levels. L-651,896 (2,3-dihydro-6-[3-(2-hydroxymethyl)phenyl-2-propenyl]-5-benzofuranol), a 5-lipoxygenase inhibitor, reduced leukotriene levels but did not reduce swelling or prostaglandin levels. A combination of indomethacin and L-651,896 reduced eicosanoid levels but did not reduce swelling. These data suggested that the reduction in tissue levels of 5-lipoxygenase or cyclooxygenase oxygenation products of arachidonic acid either singularly or together did not result in the concomitant reduction of the inflammation associated with oxazolone-induced delayed hypersensitivity.


Subject(s)
Cyclooxygenase Inhibitors , Hypersensitivity, Delayed/metabolism , Inflammation/prevention & control , Lipoxygenase Inhibitors , Oxazoles/pharmacology , Oxazolone/pharmacology , Animals , Dexamethasone/analysis , Dinoprostone , Female , Leukotriene B4/analysis , Mice , Prostaglandins E/analysis , SRS-A/analysis
10.
Arzneimittelforschung ; 38(3): 372-8, 1988 Mar.
Article in English | MEDLINE | ID: mdl-3132928

ABSTRACT

3-Hydroxy-5-trifluoromethyl-N-(2-(2-thienyl)-2-phenyl-ethenyl)- benzo (b) thiophene-2-carboxamide (L-652,343) is an inhibitor of cyclooxygenase and 5-lipoxygenase in vitro and inhibits the synthesis of the products of both these pathways in whole cells. L-652,343 is an inhibitor of the acute edema induced by carrageenan in vivo and is active topically in suppressing arachidonic acid induced inflammation in the skin. The compound is an effective inhibitor of the chronic inflammation of adjuvant and type II collagen induced polyarthritis. L-652,343 is an extremely potent analgesic in models of yeast and platelet activating factor induced hyperalgesia in rats and phenylbenzoquinone-induced writhing in mice. The fever induced by Brewer's yeast is lowered by L-652,343. The ulcerogenicity and gastric bleeding induced by L-652,343 is extremely low, providing a favorable therapeutic index which is superior to that of indomethacin, piroxicam and phenylbutazone.


Subject(s)
Arachidonate Lipoxygenases/antagonists & inhibitors , Cyclooxygenase Inhibitors , Lipoxygenase Inhibitors , Thiophenes/pharmacology , Analgesics , Animals , Anti-Inflammatory Agents , Anti-Inflammatory Agents, Non-Steroidal , Dogs , Female , Male , Mice , Mice, Inbred Strains , Rats , Rats, Inbred Strains , Stomach Ulcer/chemically induced , Thiophenes/toxicity
11.
Prostaglandins ; 28(2): 271-8, 1984 Aug.
Article in English | MEDLINE | ID: mdl-6505225

ABSTRACT

Platelet-activating factor (PAF), a phospholipid product of neutrophils, alveolar macrophages, monocytes, and platelets and an important mediator of inflammatory reactions, was studied for its ability to evoke hindpaw edema in the rat. PAF caused edema, peaking at 1 hr and gradually declining over the next 2 hr. The H1 and H2 antihistamines, mepyramine and cimetidine, the serotonin/histamine antagonist, cyproheptadine, and the serotonin antagonist, methysergide, were ineffective in reducing PAF-induced paw edema. Indomethacin, acetylsalicylic acid, and dexamethasone did not inhibit the peak edematous response but significant reduction was noted with only dexamethasone at 3 hr. Prazosin and propranolol did not prevent PAF-induced edema, whereas, yohimbine, phentolamine, rauwolscine, verapamil and theophylline partially inhibited edema. Clonidine and guanfacine did not induce edema when injected into the rat hindpaw. These results suggest that PAF elicits edema at vascular sites of the rat hindpaw which are partially dependent on extracellular Ca2+ movement, are not due to alpha-1 or alpha-2-adrenoreceptor stimulation, histamine, serotonin, or prostaglandin activity, and demonstrates variable sensitivities to agents blocking Ca2+ entry. Inhibition of specific PAF-sensitive receptors await the discovery of specific PAF antagonists.


Subject(s)
Edema/physiopathology , Muscles/blood supply , Platelet Activating Factor/toxicity , Animals , Carrageenan , Dexamethasone/pharmacology , Dose-Response Relationship, Drug , Hindlimb , Indomethacin/pharmacology , Male , Phentolamine/pharmacology , Rats , Rats, Inbred Strains , Regional Blood Flow/drug effects , Theophylline/pharmacology , Verapamil/pharmacology , Yohimbine/pharmacology
12.
Am J Trop Med Hyg ; 32(6): 1242-50, 1983 Nov.
Article in English | MEDLINE | ID: mdl-6418014

ABSTRACT

Experimental studies were undertaken in tissue culture and mice infected with a cloned derivative of Trypanosoma cruzi, Y strain to determine the efficacy of two 2-substituted 5-nitroimidazole compounds, MK-436 and L634,549. The use of an X-irradiated myoblast culture system proved better than a conventional fibroblast culture for assaying the activity of compounds against intracellular parasite stages. MK-436 showed activity against amastigotes at a level of 25 micrograms/ml and L634,549 a dihydroxy metabolite of MK-436 showed activity 2 micrograms/ml. Neither compound caused morphological damage to the host cells at levels tested (250 micrograms/ml). By contrast, nifurtimox, which was active at 2 micrograms/ml, caused significant host cell damage at 100 micrograms/ml. In mice, studies in the chronic infection showed that MK-436 was curative at a level of 30 mg/kg if given daily for 20 days. Neither nifurtimox nor benznidazole were fully curative when given at a level of 100 mg/kg daily for 20 days. These studies showed that administration of MK-436 with a suitable solvent, PEG 400, enhanced its efficacy fourfold, and that efficacy was also enhanced by increasing the treatment interval. Since MK-436 showed better efficacy in chronic rodent infections than either nifurtimox or benznidazole, such compounds should be evaluated for efficacy in human Chagas' disease.


Subject(s)
Antiprotozoal Agents/therapeutic use , Chagas Disease/drug therapy , Nitroimidazoles/therapeutic use , Trypanosoma cruzi/drug effects , Animals , Benzimidazoles/therapeutic use , Cell Line , Drug Evaluation, Preclinical , Female , Fibroblasts , Humans , Mice , Mice, Inbred BALB C , Muscles , Nifurtimox/therapeutic use , Rats
13.
Prostaglandins ; 26(4): 615-22, 1983 Oct.
Article in English | MEDLINE | ID: mdl-6658006

ABSTRACT

The purpose of this study was to learn whether a number of Ca2+ antagonists were effective in reducing contractile responses of the isolated ileum of the sensitized and normal guinea pig. Contractions of the normal ileum in response to LTD4, acetylcholine, histamine, and potassium chloride were obtained before and after verapamil, diltiazem and papaverine. Ovalbumin-induced contractions of the ovalbumin-sensitized ileum were obtained in the presence of the three Ca2+ antagonists. In the normal ileum, all the Ca2+ antagonists were highly effective in diminishing the contractile responses to LTD4, acetylcholine, histamine and potassium chloride. In the sensitized ileum, ovalbumin-evoked contractions, with subsequent release of a potent contractile mediator (presumably SRS-A), were Ca2+-dependent since verapamil, diltiazem and papaverine caused a concentration-related reduction of contractions. Thus, the influx of extracellular Ca2+ plays a key role in the contractile responses of the normal and sensitized guinea pig ileum when stimulated by various potent agonists acting on specific receptors or on the cell membrane.


Subject(s)
Calcium Channel Blockers/pharmacology , Ileum/drug effects , Muscle Contraction/drug effects , Acetylcholine/pharmacology , Animals , Diltiazem/pharmacology , Female , Guinea Pigs , Histamine/pharmacology , Papaverine/pharmacology , Potassium Chloride/pharmacology , SRS-A/pharmacology , Verapamil/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...